Pharmacogenetics of Voriconazole: CYP2C19 but Also CYP3A4 Need to Be Genotyped.
Université Grenoble Alpes, Grenoble, France.|INSERM U1042, HP2, Grenoble, France.|Laboratoire de Pharmacologie-Toxicologie, Grenoble University Hospital, Grenoble, France.
E
E
Gautier-Veyret
Laboratoire de Pharmacologie-Toxicologie, Grenoble University Hospital, Grenoble, France.
X
X
Fonrose
Université Grenoble Alpes, Grenoble, France.|INSERM U1042, HP2, Grenoble, France.|Laboratoire de Pharmacologie-Toxicologie, Grenoble University Hospital, Grenoble, France.
F
F
Stanke-Labesque
D000935:Antifungal Agents; D065731:Cytochrome P-450 CYP2C19 / Q000235:genetics*; D051544:Cytochrome P-450 CYP3A / Q000235:genetics; D005838:Genotype; D010597:Pharmacogenetics; D065819:Voriconazole
D000935:Antifungal Agents; D065731:Cytochrome P-450 CYP2C19; D051544:Cytochrome P-450 CYP3A; D065819:Voriconazole